Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas F Hottinger

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Current Opinion in Neurology|September 23, 2016
Neurologic complications of immune checkpoint inhibitorsAndreas F Hottinger
Current Opinion in Neurology|September 23, 2016
Neurooncology: a Swiss army knife specialtyAndreas F Hottinger
Current Neurology and Neuroscience Reports|May 10, 2007
Update on the management of familial central nervous system tumor syndromesAndreas F Hottinger, Yasmin Khakoo
Current Treatment Options in Neurology|June 16, 2009
Neuro-oncology of Neurofibromatosis Type 1Andreas F Hottinger, Yasmin Khakoo
Journal of Child Neurology|December 4, 2009
Neurooncology of familial cancer syndromesAndreas F Hottinger, Yasmin Khakoo
Onkologie|June 13, 2008
Management of malignant glioma--quo vadis?Roger Stupp, Andreas F Hottinger
Cancers|November 9, 2024
Cancer Therapy-Induced EncephalitisNicolas P Desbaillets, Andreas F Hottinger
Revue Medicale Suisse|October 25, 2017
[Revised WHO classification 2016 of gliomas : what's new ?]Jean Philippe Brouland, Andreas F Hottinger
Current Opinion in Neurology|March 21, 2019
Neurotoxicity associated with cancer immunotherapy: immune checkpoint inhibitors and chimeric antigen receptor T-cell therapyClaire Perrinjaquet, Nicolas Desbaillets, Andreas F Hottinger
Chinese Journal of Cancer|January 4, 2014
Standards of care and novel approaches in the management of glioblastoma multiformeAndreas F Hottinger, Roger Stupp, Krisztian Homicsko
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Current Opinion in Neurology|September 23, 2016
Neurologic complications of immune checkpoint inhibitorsAndreas F Hottinger
Current Opinion in Neurology|September 23, 2016
Neurooncology: a Swiss army knife specialtyAndreas F Hottinger
Current Neurology and Neuroscience Reports|May 10, 2007
Update on the management of familial central nervous system tumor syndromesAndreas F Hottinger, Yasmin Khakoo
Current Treatment Options in Neurology|June 16, 2009
Neuro-oncology of Neurofibromatosis Type 1Andreas F Hottinger, Yasmin Khakoo
Journal of Child Neurology|December 4, 2009
Neurooncology of familial cancer syndromesAndreas F Hottinger, Yasmin Khakoo
Onkologie|June 13, 2008
Management of malignant glioma--quo vadis?Roger Stupp, Andreas F Hottinger
Cancers|November 9, 2024
Cancer Therapy-Induced EncephalitisNicolas P Desbaillets, Andreas F Hottinger
Revue Medicale Suisse|October 25, 2017
[Revised WHO classification 2016 of gliomas : what's new ?]Jean Philippe Brouland, Andreas F Hottinger
Current Opinion in Neurology|March 21, 2019
Neurotoxicity associated with cancer immunotherapy: immune checkpoint inhibitors and chimeric antigen receptor T-cell therapyClaire Perrinjaquet, Nicolas Desbaillets, Andreas F Hottinger
Chinese Journal of Cancer|January 4, 2014
Standards of care and novel approaches in the management of glioblastoma multiformeAndreas F Hottinger, Roger Stupp, Krisztian Homicsko
Pageof 9